X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (43932) 43932
Publication (2470) 2470
Book Review (530) 530
Newsletter (276) 276
Book Chapter (163) 163
Magazine Article (141) 141
Dissertation (77) 77
Conference Proceeding (56) 56
Book / eBook (22) 22
Reference (10) 10
Trade Publication Article (8) 8
Newspaper Article (7) 7
Web Resource (7) 7
Data Set (6) 6
Paper (6) 6
Government Document (1) 1
Journal / eJournal (1) 1
Presentation (1) 1
Transcript (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (29581) 29581
male (18303) 18303
angiotensin-converting enzyme inhibitors - therapeutic use (17808) 17808
female (13597) 13597
animals (11903) 11903
middle aged (9931) 9931
index medicus (9554) 9554
angiotensin-converting enzyme inhibitors - pharmacology (8717) 8717
hypertension - drug therapy (8709) 8709
aged (8603) 8603
hypertension (7555) 7555
cardiac & cardiovascular systems (6735) 6735
rats (6640) 6640
adult (6318) 6318
blood pressure - drug effects (6253) 6253
pharmacology & pharmacy (5692) 5692
antihypertensive agents - therapeutic use (5043) 5043
angiotensin-converting enzyme inhibitors (5014) 5014
peripheral vascular disease (4795) 4795
angiotensin (4330) 4330
heart failure - drug therapy (4308) 4308
treatment outcome (4200) 4200
risk factors (3960) 3960
angiotensin-converting enzyme inhibitors - adverse effects (3804) 3804
adrenergic beta-antagonists - therapeutic use (3747) 3747
mortality (3696) 3696
captopril (3627) 3627
drug therapy, combination (3606) 3606
medicine, general & internal (3574) 3574
angiotensin-converting enzyme inhibitors - administration & dosage (3568) 3568
blood-pressure (3488) 3488
heart failure (3472) 3472
hypertension - physiopathology (3470) 3470
renin-angiotensin system - drug effects (3270) 3270
converting enzyme-inhibitors (3196) 3196
ace inhibitors (3024) 3024
blood pressure (2879) 2879
urology & nephrology (2829) 2829
enalapril (2785) 2785
renin-angiotensin system (2660) 2660
time factors (2637) 2637
calcium channel blockers - therapeutic use (2515) 2515
angiotensin-converting enzyme (2387) 2387
enzymes (2334) 2334
hypertension - complications (2287) 2287
angiotensin receptor antagonists (2233) 2233
captopril - pharmacology (2225) 2225
aged, 80 and over (2188) 2188
diuretics - therapeutic use (2171) 2171
drug therapy (2169) 2169
double-blind method (2105) 2105
angiotensin ii type 1 receptor blockers - therapeutic use (2093) 2093
dose-response relationship, drug (2000) 2000
myocardial-infarction (1993) 1993
antihypertensive agents - pharmacology (1952) 1952
therapy (1878) 1878
heart failure - physiopathology (1839) 1839
follow-up studies (1770) 1770
enalapril - therapeutic use (1757) 1757
research (1752) 1752
angiotensin converting enzyme (1747) 1747
renin-angiotensin system - physiology (1717) 1717
enzyme inhibitors (1693) 1693
care and treatment (1692) 1692
heart-failure (1690) 1690
randomized controlled trials as topic (1648) 1648
disease (1646) 1646
retrospective studies (1646) 1646
prognosis (1638) 1638
clinical trials as topic (1621) 1621
prospective studies (1613) 1613
angiotensin ii (1592) 1592
risk (1557) 1557
hemodynamics - drug effects (1549) 1549
captopril - therapeutic use (1532) 1532
diabetes (1515) 1515
angiotensin-converting enzyme inhibitor (1479) 1479
analysis (1478) 1478
bradykinin (1477) 1477
kidney - drug effects (1467) 1467
peptidyl-dipeptidase a - metabolism (1464) 1464
left-ventricular dysfunction (1446) 1446
rats, sprague-dawley (1446) 1446
medicine & public health (1443) 1443
angiotensin converting enzyme inhibitors (1441) 1441
converting-enzyme-inhibitor (1433) 1433
prevention (1407) 1407
converting-enzyme-inhibitors (1400) 1400
enalapril - pharmacology (1379) 1379
health aspects (1378) 1378
rats, wistar (1370) 1370
myocardial infarction - drug therapy (1366) 1366
renin - blood (1357) 1357
rats, inbred shr (1352) 1352
physiology (1349) 1349
angiotensin receptor antagonists - therapeutic use (1343) 1343
angiotensin-ii (1334) 1334
disease progression (1327) 1327
proteinuria (1326) 1326
acute myocardial-infarction (1323) 1323
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (40029) 40029
French (822) 822
Japanese (749) 749
Russian (726) 726
German (607) 607
Chinese (288) 288
Spanish (275) 275
Polish (207) 207
Italian (172) 172
Portuguese (110) 110
Danish (84) 84
Hungarian (84) 84
Czech (79) 79
Dutch (69) 69
Norwegian (56) 56
Korean (38) 38
Finnish (30) 30
Slovak (25) 25
Hebrew (22) 22
Ukrainian (22) 22
Swedish (21) 21
Romanian (19) 19
Serbian (17) 17
Croatian (16) 16
Turkish (16) 16
Lithuanian (13) 13
Persian (5) 5
Bosnian (4) 4
Bulgarian (4) 4
Slovenian (3) 3
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


JACC (Journal of the American College of Cardiology), ISSN 0735-1097, 2014, Volume 63, Issue 7, pp. 650 - 658
Objectives The study objective was to assess the association between angiotensin-converting enzyme inhibitor (ACEI)/angiotensin receptor blocker (ARB) use and... 
Cardiovascular | Internal Medicine | mortality | angiotensin-converting enzyme inhibitors | chronic kidney disease | angiotensin receptor blockers | SURVIVAL | SYSTEM INHIBITORS | CARDIAC & CARDIOVASCULAR SYSTEMS | PROPENSITY SCORE ANALYSIS | MYOCARDIAL-INFARCTION | ACE-INHIBITION | DIABETIC-NEPHROPATHY | CHRONIC RENAL-INSUFFICIENCY | HYPERTENSIVE PATIENTS | HEMODIALYSIS-PATIENTS | CONGESTIVE-HEART-FAILURE | Receptors, Angiotensin - metabolism | Follow-Up Studies | Angiotensin II Type 1 Receptor Blockers - therapeutic use | Humans | Middle Aged | Male | Renal Insufficiency, Chronic - drug therapy | Renal Insufficiency, Chronic - metabolism | Angiotensin-Converting Enzyme Inhibitors - therapeutic use | Aged, 80 and over | Renal Insufficiency, Chronic - mortality | Female | Aged | Cohort Studies | Hypertension | Sects | Chronic kidney failure | Patient outcomes | Mortality | Angiotensin | ACE inhibitors | Medical research | Analysis | Medicine, Experimental | Angiotensin-converting enzyme inhibitors | Laboratories | Cardiovascular disease | Subgroups | Confidence intervals | Enzyme inhibitors | Motivation | Peptidyl-dipeptidase A | Heart failure | Urine | Enzymes | Statistical analysis | Kidneys | Comorbidity | Diabetes mellitus | Calendars | Regression analysis | Patients | Inhibitors | Statistical models | Converting | Pharmacy | Coronary vessels | Diabetes | Kidney diseases | Potassium
Journal Article
Journal Article
Pharmacogenetics and Genomics, ISSN 1744-6872, 09/2013, Volume 23, Issue 9, pp. 470 - 478
Journal Article
Chemical Communications, ISSN 1359-7345, 03/2015, Volume 51, Issue 19, pp. 3973 - 3976
We report herein a novel iridium(III) complex 1 as an antitumour necrosis factor agent and the first metal-based inhibitor of TACE enzymatic activity. Complex... 
IN-VITRO | INFLAMMATORY-BOWEL-DISEASE | CROHNS-DISEASE | DRUG DISCOVERY | COMPLEXES | ADAMS | TNF-ALPHA | INFLIXIMAB | CHEMISTRY, MULTIDISCIPLINARY | TACE INHIBITORS | EGFR | Enzymes | Phosphorylation | Inhibitors | Converting | Inhibition | Secretions | Tumors
Journal Article
Immunology and Allergy Clinics of North America, ISSN 0889-8561, 11/2006, Volume 26, Issue 4, pp. 725 - 737
Angioedema, characterized by swelling of the lips, face, and tongue, occurs in anywhere from 0.1% to 6% of angiotensin-converting enzyme (ACE) inhibitor users.... 
ACE-INHIBITORS | PLASMA EXTRAVASATION | ACTIVATION | ALLERGY | CARDIOVASCULAR EVENTS | DES-ARG-BRADYKININ | RECEPTOR | RISK | IMMUNOLOGY | AMINOPEPTIDASE-P | BLOOD-PRESSURE | BRADYKININ | Genetic Predisposition to Disease | Animals | Pedigree | Humans | Angiotensin-Converting Enzyme Inhibitors - adverse effects | Angioedema - chemically induced | Angioedema - genetics
Journal Article
Biosensors and Bioelectronics, ISSN 0956-5663, 02/2017, Volume 88, pp. 122 - 129
In this work, a novel biosensor based on electrochemically reduced graphene oxide and iridium oxide nanoparticles for the detection of angiotensin-converting... 
Enzyme inhibition | Iridium oxide nanoparticles | Angiotensin-converting enzyme inhibitor | Captopril detection | Enzyme biosensors | Electrochemically reduced graphene oxide | GOLD NANOPARTICLES | ELECTROCHEMISTRY | CHEMISTRY, ANALYTICAL | VOLTAMMETRIC DETERMINATION | TYROSINASE | WATER OXIDATION | NANOSCIENCE & NANOTECHNOLOGY | CAPTOPRIL | CARBON-PASTE ELECTRODE | IN-VITRO | BIOPHYSICS | POLYPHENOL OXIDASE | BIOTECHNOLOGY & APPLIED MICROBIOLOGY | ELECTROCATALYTIC DETERMINATION | ANODIC HYDROXYLATION | Enzymes, Immobilized - chemistry | Limit of Detection | Angiotensin-Converting Enzyme Inhibitors - analysis | Captopril - pharmacology | Nanoparticles - chemistry | Oxidation-Reduction | Humans | Nanoparticles - ultrastructure | Monophenol Monooxygenase - antagonists & inhibitors | Angiotensin-Converting Enzyme Inhibitors - blood | Biosensing Techniques - methods | Electrochemical Techniques - methods | Angiotensin-Converting Enzyme Inhibitors - pharmacology | Graphite - chemistry | Agaricales - enzymology | Iridium - chemistry | Captopril - analysis | Monophenol Monooxygenase - chemistry | Captopril - blood | Heart failure | Nanoparticles | Catechin | Enzyme inhibitors | Graphene | Captopril | Graphite | Detectors | Angiotensin | ACE inhibitors | Nanotechnology | Enzymes | Oxides | Iridium | Biosensors | Tyrosinase
Journal Article
Journal Article
Scientific Reports, ISSN 2045-2322, 12/2018, Volume 8, Issue 1, pp. 3332 - 10
Angiotensin-converting enzyme inhibitors (ACEIs) can improve the fibrotic processes in many internal organs. Recent studies have shown a relationship between... 
Cell proliferation | Angiotensin-converting enzyme inhibitors | Flow cytometry | Enzymes | Phosphorylation | TAK1 protein | Transforming growth factor | Western blotting | Vascularization | Peptidyl-dipeptidase A | Smad2 protein | Collagen | Angiotensin | Fibroblasts
Journal Article
FASEB Journal, ISSN 0892-6638, 09/2011, Volume 25, Issue 9, pp. 2911 - 2920
Journal Article
Journal of Hypertension, ISSN 0263-6352, 11/2011, Volume 29, Issue 11, pp. 2273 - 2277
Objective To investigate, for the first time, the frequency of recurrences of angiotensin-converting enzyme inhibitor (ACE-I)-related angioedema after the... 
angioedema | angiotensin-converting enzyme inhibitors | bradikynin | ANTAGONIST | ICATIBANT | HEREDITARY ANGIOEDEMA | EDEMA | RISK | PERIPHERAL VASCULAR DISEASE | BRADYKININ
Journal Article
Journal Article
JACC (Journal of the American College of Cardiology), ISSN 0735-1097, 2009, Volume 54, Issue 19, pp. 1778 - 1784
Journal Article